Petition to the Agency for Healthcare Research and Quality (AHRQ)

On February 3, 2016, a group of patient organizations and advocates sent a followup letter to the Agency for Healthcare Research and Quality (AHRQ) further detailing concerns with the 2015 AHRQ Evidence Review and reiterating their request, originally made in November 2015, to reanalyze the conclusions of AHRQ’s Evidence Review in light of the long-known concerns with the PACE trial published in The Lancet and with the Oxford case definition for CFS. You can show your support by signing this petition.

Read more: Petition to the Agency for Healthcare Research and Quality (AHRQ)


Subcategories

Congress2016 1

Documents used in Congress visits March 2016